Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil vs Carvedilol in Non-Ischemic Heart Failure
NCT00348530Phase 4Unknown
- Sponsor
- Medical University of Silesia
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of verapamil in heart failure (HF) and Non-Ischaemic Cardiomyopathy (NICM) (2 arms), sponsored by Medical University of Silesia. Primary endpoints: N-terminal pro-brain natriuretic peptide, Left Ventricular Ejection Fraction and 6 more. Status: unknown.
02
Drugs
verapamil
03
Conditions
heart failure (HF)Non-Ischaemic Cardiomyopathy (NICM)
Beyond the preview
Go deeper on NCT00348530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00348530.